Zhengze A. Shen

439 Xuanhua Road
Yongchuan, 402160, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Corrigendum to "Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer" [Neoplasia 65 (2025) 101165].

Corrigendum to "Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer" [Neoplasia 65 (2025) 101165].

Journal: Neoplasia (New York, N.Y.)
Published: July 08, 2026

Discovery of ZJC-11 as a Novel Selective CDK7 Inhibitor for Treating Triple-Negative Breast Cancer by Inducing Cell Senescence.

Discovery of ZJC-11 as a Novel Selective CDK7 Inhibitor for Treating Triple-Negative Breast Cancer by Inducing Cell Senescence.

Journal: Journal of medicinal chemistry
Published: March 10, 2026

Effect of polymyxin resistance evolution on the fitness costs of Acinetobacter baumannii and the underlying mechanisms of polymyxin resistance.

Effect of polymyxin resistance evolution on the fitness costs of Acinetobacter baumannii and the underlying mechanisms of polymyxin resistance.

Journal: Scientific reports
Published: January 15, 2026

Acute fluoroacetamide poisoning with reversible leukoencephalopathy: A case report and literature review highlighting the effectiveness of acetamide and the diagnostic value of neuroimaging.

Acute fluoroacetamide poisoning with reversible leukoencephalopathy: A case report and literature review highlighting the effectiveness of acetamide and the diagnostic value of neuroimaging.

Journal: Medicine
Published: October 05, 2025

β-Caryophyllene modulates the JAK2/STAT3 signaling pathway to downregulate neutrophil extracellular traps and alleviate cerebral ischemia-reperfusion injury.

β-Caryophyllene modulates the JAK2/STAT3 signaling pathway to downregulate neutrophil extracellular traps and alleviate cerebral ischemia-reperfusion injury.

Journal: Metabolic brain disease
Published: March 10, 2025

Evaluation of anti-diabetic effects of glimepiride/metformin cocrystal.

Evaluation of anti-diabetic effects of glimepiride/metformin cocrystal.

Journal: Journal of drug targeting
Published: November 01, 2024

A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system.

A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system.

Journal: Expert opinion on drug safety
Published: October 19, 2024

Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer.

Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer.

Journal: Neoplasia (New York, N.Y.)
Published: August 30, 2024

The 7-Methylguanosine (m7G) methylation METTL1 acts as a potential biomarker of clear cell renal cell carcinoma progression.

The 7-Methylguanosine (m7G) methylation METTL1 acts as a potential biomarker of clear cell renal cell carcinoma progression.

Journal: Translational oncology
Published: May 04, 2024

A real-world pharmacovigilance analysis of the FDA adverse event reporting system events for polatuzumab vedotin.

A real-world pharmacovigilance analysis of the FDA adverse event reporting system events for polatuzumab vedotin.

Journal: Expert opinion on drug safety
Published: May 02, 2024

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system.

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system.

Journal: Frontiers in pharmacology
Published: August 19, 2023

VPS34-IN1 induces apoptosis of ER+ breast cancer cells via activating PERK/ATF4/CHOP pathway.

VPS34-IN1 induces apoptosis of ER+ breast cancer cells via activating PERK/ATF4/CHOP pathway.

Journal: Biochemical pharmacology
Published: February 27, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026